Adi Diab, MD of MD Anderson Cancer Center discusses a common question he’s asked, regarding the use of NKTR-214 for…
Adi Diab, MD of MD Anderson Cancer Center gives an overview of his abstracts, which focus on the use of…
Steven E. Benner, MD, Senior Vice President and Global Therapeutic Head for Oncology at Astellas Oncology discusses whether or not…
Steven E. Benner, MD, Senior Vice President and Global Therapeutic Head for Oncology at Astellas Oncology the future of treatment…
Steven E. Benner, MD, Senior Vice President and Global Therapeutic Head for Oncology at Astellas Oncology discusses a phase 1…
Steven E. Benner, MD, Senior Vice President and Global Therapeutic Head for Oncology at Astellas Oncology gives an overview of…
Steven E. Benner, MD, Senior Vice President and Global Therapeutic Head for Oncology at Astellas Oncology discusses the use of…
Steven E. Benner, MD, Senior Vice President and Global Therapeutic Head for Oncology at Astellas Oncology gives an overview of…
Kelly Garneski Paulson, MD of Seattle Cancer Care Alliance gives an overview and background context on her abstract which focuses…
Kelly Garneski Paulson, MD of Seattle Cancer Care Alliance discusses what’s next in the future for her clinical trial on…
Kelly Garneski Paulson, MD of Seattle Cancer Care Alliance explains what epitopes are in merkel cell carcinoma. This was recorded…
Kelly Garneski Paulson, MD of Seattle Cancer Care Alliance gives an overview of her poster presentation which focuses on two…
Nancy E. Davidson, MD of Seattle Cancer Care Alliance discusses the promising data coming out of SCCA for acute lymphoblastic…
Nancy E. Davidson, MD of Seattle Cancer Care Alliance stresses the importance of patient advocacy, quality of life, and cancer…
Nancy E. Davidson, MD of Seattle Cancer Care Alliance gives an overview of a joint session between American Association of…
Nancy E. Davidson, MD of Seattle Cancer Care Alliance discusses plans the center has on the future of cost and…
Shinji Atagi, MD of National Hospital Organization Kinki-Chuo Chest Medical Center gives an overview of a randomized trial done by…
Jonathan Lim, MD, Chairman and CEO of Ignyta, Inc. discusses what’s next for entrectinib and his hopes to launch the…
Jonathan Lim, MD, Chairman and CEO of Ignyta, Inc. gives an overview of his clinical trial, STARTRK-2 and the use…
Jonathan Lim, MD, Chairman and CEO of Ignyta, Inc. explains the impact of Entrectinib and the STARTRK-2 trial on clinical…
Jonathan Lim, MD, Chairman and CEO of Ignyta, Inc. explains genomic testing in finding patients for the clinical trial, STARTRK-2.…
David Michael Hyman, MD of Memorial Sloan-Kettering talks of his hopes for LOXO-101 in future clinical practice and clinical trials…
David Michael Hyman, MD of Memorial Sloan-Kettering gives an overview his presentation, which focuses on the efficacy of larotrectinib (LOXO-101)…
David Michael Hyman, MD of Memorial Sloan-Kettering explains common questions physicians ask him concerning his study on the efficacy of…
William P. Harris, MD of Seattle Cancer Care Alliance gives an overview of some of the promising data coming out…
William P. Harris, MD of Seattle Cancer Care Alliance discusses the treatment trends for upper gastrointestinal cancers, which include targeted…
William P. Harris, MD of Seattle Cancer Care Alliance explains some of the common questions asked regarding the phase II…
William P. Harris, MD of Seattle Cancer Care Alliance discusses metastatic pancreatic cancer for the 2017 ASCO Annual Meeting in…
Julie R. Gralow, MD of Seattle Cancer Care Alliance gives an overview of her presentation, SWOG S0221 updated: Randomized comparison…
Julie R. Gralow, MD of Seattle Cancer Care Alliance explains the impact of the trial on clinical practice, arguing that…
Davendra Sohal, MD of Cleveland Clinic discusses the treatment trends for pancreatic cancer, which include understanding the mechanisms of resistance…
Davendra Sohal, MD of Cleveland Clinic discusses the impact of perioperative chemotherapy on management of resectable pancreatic cancer. This was…
Davendra Sohal, MD of Cleveland Clinic gives an overview of his presentation, Perioperative mFOLFIRINOX vs. Gemcitabine/nab-Paclitaxel as Therapy for Resectable…
Jason A. Chesney, MD, PhD of the James Graham Brown Cancer Center discusses the impact of the talimogene laherparepvec and…
Jason A. Chesney, MD, PhD of the James Graham Brown Cancer Center talks of his hopes for the expansion of…
Jason A. Chesney, MD, PhD of the James Graham Brown Cancer Center discusses the most exciting and interesting presentations coming…
Jason A. Chesney, MD, PhD of the James Graham Brown Cancer Center talks of the common questions most physicians ask…
Jason A. Chesney, MD, PhD of the James Graham Brown Cancer Center gives an overview of his presentation which focused…
Bernardo H. Goulart, MD, MS of Seattle Cancer Care Alliance explains the impact of natural language processing (NLP) on future…
Bernardo H. Goulart, MD, MS of Seattle Cancer Care Alliance discusses the use of natural language processing (NLP) for patients…
Michael J. Birrer, MD, PhD, Director of the University of Alabama at Birmingham Comprehensive Cancer Center gives an overview of…
Michael J. Birrer, MD, PhD, Director of the University of Alabama at Birmingham Comprehensive Cancer Center discusses a collaborated study…
Michael J. Birrer, MD, PhD discusses his role as newly appointed director for the University of Alabama at Birmingham Comprehensive…
Michael J. Birrer, MD, PhD, Director of the University of Alabama at Birmingham Comprehensive Cancer Center gives an overview of…
Manmeet S. Ahluwalia, MD of Cleveland Clinic discusses three abstracts presented at ASCO 2017, highlighting the management of brain metastases…
Manmeet S. Ahluwalia, MD of Cleveland Clinic gives an overview of his presentation, What Drives Patient Outcomes in Brain Metastases:…
Vivek Subbiah, MD of MD Anderson Cancer Center discusses the impact of his study of vemurafenib in NSCLC patients on…
Vivek Subbiah, MD of MD Anderson Cancer Center discusses the exciting and new data presented at ASCO, which shows promise…
Vivek Subbiah, MD of MD Anderson Cancer Center gives an overview of his presentation, which focused on the use of…
Alan P. Venook, MD of UCSF Helen Diller Family Comprehensive Cancer Center gives an overview of his presentation, which focused…
Alan P. Venook, MD of UCSF Helen Diller Family Comprehensive Cancer Center gives an overview of the exciting presentations discussed…
Mizuki Nishino, MD, MPH of Dana-Farber Cancer Institute discusses the common questions and concerns regarding her presentation on commercially prescribed…
Mizuki Nishino, MD, MPH of Dana-Farber Cancer Institute gives an overview of her presentation, Tumor response dynamics of advanced non-small-cell…
Mizuki Nishino, MD, MPH of Dana-Farber Cancer Institute discusses the treatment trends for lung cancer and oncology overall, which include…
Alok Khorana, MD of Cleveland Clinic gives an overview his presentation, which focuses on time to initiating (TTI) cancer therapy…
Alok Khorana, MD of Cleveland Clinic discusses the skepticism surrounding timing to initiating (TTI) cancer therapy. This was recorded at…
Alok Khorana, MD of Cleveland Clinic gives an overview of the treatment trends for gastrointestinal cancers, which includes the use…
Daniel A. Goldstein, MD of Davidoff Cancer Center gives an overview of the treatment trends for non-small cell lung cancer…
Daniel A. Goldstein, MD of Davidoff Cancer Center discusses the impact of weight-based dosing on patients’ affordability of the drug.…
Daniel A. Goldstein, MD of Davidoff Cancer Center explains the questions regarding the equivalence of dosing in milligrams versus milligrams…
Daniel A. Goldstein, MD of Davidoff Cancer Center gives an overview of his presentation, involving dosing of pembrolizumab in non-small…
Brian Slomovitz, MD of University of Miami Health System and Sylvester Comprehensive Cancer Center discusses the challenges of the AIM2CERV…
Brian Slomovitz, MD of University of Miami Health System and Sylvester Comprehensive Cancer Center discusses the take-home message coming out…
Brian Slomovitz, MD of University of Miami Health System and Sylvester Comprehensive Cancer Center explains the importance of targeting HPV-associated…
Brian Slomovitz, MD of University of Miami Health System and Sylvester Comprehensive Cancer Center explains the goal of the AIM2CERV…
Brian Slomovitz, MD of University of Miami Health System and Sylvester Comprehensive Cancer Center discusses the use of AIM2CERV’s axalimogene…
Brian Slomovitz, MD of University of Miami Health System and Sylvester Comprehensive Cancer Center gives an overview of his presentation,…
Brian Slomovitz, MD of University of Miami Health System and Sylvester Comprehensive Cancer Center discusses the impact of the AIM2CERV…
Briggs Morrison MD, CEO of Syndax Pharmaceuticals, Inc. discusses the most common questions he has been asked regarding the ENCORE…
Briggs Morrison MD, CEO of Syndax Pharmaceuticals, Inc. gives an overview of a few presentations that he finds the most…
Briggs Morrison MD, CEO of Syndax Pharmaceuticals, Inc. gives an overview of his presentation, Abstract #9529 ENCORE 601: A phase…
Briggs Morrison MD, CEO of Syndax Pharmaceuticals, Inc. discusses the treatment trends in 2017 for advanced melanoma. This was recorded…
Krishnansu S. Tewari, MD of University of California, Irvine explains what CA4P is. CA4P is a vascular disrupting agent (VDA),…
Krishnansu S. Tewari, MD of University of California, Irvine discusses the most recent results from the FOCUS trial, including the…
Krishnansu S. Tewari, MD of University of California, Irvine gives an overview of the FOCUS trial, which is sponsored by…
Krishnansu S. Tewari, MD of University of California, Irvine discusses the impact of the FOCUS trial on clinical practice, explaining…
Mark Rutstein, Vice President of Oncology Development of Bayer discusses the xofigo injection, a treatment method for patients with castration-resistant…
Mark Rutstein, Vice President of Oncology Development of Bayer gives an overview of three abstracts that discussed the use of…
Mark Rutstein, Vice President of Oncology Development of Bayer discusses his take on the treatment trends for 2017 and 2018,…
Mark Rutstein, Vice President of Oncology Development of Bayer discusses the RIFTOS trial, which focused on the use of sorafenib…
Mark Rutstein, Vice President of Oncology Development of Bayer gives an overview of two poster presentations that focus on the…
Mark Rutstein, Vice President of Oncology Development of Bayer discusses Bayers current and approved products and new and diverse advances…
Mark Rutstein, Vice President of Oncology Development of Bayer gives an overview of the ARASENS study, which is a phase…
Howard S. Hochster, MD of Yale School of Medicine gives an overview of his presentation, The Impact of Molecular Subsets…
Howard S. Hochster, MD of Yale School of Medicine discusses the importance of recommending molecular testing early on to patients…
Howard S. Hochster, MD of Yale School of Medicine discusses the impact of molecular testing and screening on potential clinical…
Christopher Crane, MD of Memorial Sloan-Kettering gives an overview of his presentation, What is the Optimal Neoadjuvant Strategy in Pancreatic…
Christopher Crane, MD of Memorial Sloan-Kettering gives an overview of his presentation, Does Radiation Therapy Play a Role in Gastric…
Mark A. Schattner, MD of Memorial Sloan-Kettering gives an overview of his presentation, Novel Endoscopic Management of Pancreaticobiliary Cancers, which…
Mark A. Schattner, MD of Memorial Sloan-Kettering explains whether or not there is screen for pancreatic cancer. This was recorded…
David Ilson, MD, PhD of Memorial Sloan-Kettering discusses questions from the audience that focused on the appropriate chemotherapy for gastric…
David Ilson, MD, PhD of Memorial Sloan-Kettering explains the impact of radiation therapy on clinical practice. He argues that adding…
David Ilson, MD, PhD of Memorial Sloan-Kettering gives an overview of his presentation, Debate: Does Radiation Therapy Play a Role…
Ghassan Abou-Alfa, MD of Memorial Sloan-Kettering discusses his presentation, Overview of Novel Treatments for HCC in the Era of Hep…
Ghassan Abou-Alfa, MD of Memorial Sloan-Kettering discusses the impact of regorafenib for hepatocellular carcinoma (HCC) treatment. This was recorded at…
Jonathan R. Strosberg, MD of Moffitt Cancer Center gives an overview of his presentation, Management of Neuroendocrine Tumors, which was…
Jonathan R. Strosberg, MD of Moffitt Cancer Center discusses the impact of circulating tumor DNA on oncology treatment and management.…
Jonathan R. Strosberg, MD of Moffitt Cancer Center gives an overview of his presentation, Is There a Role for Surgical…
Yelena Yuriy Janjigian, MD, Memorial Sloan-Kettering gives an overview of her presentation, Molecular Subtyping/Profiling and Update in HER2 Targeted Therapy,…
Yelena Yuriy Janjigian, MD of Memorial Sloan-Kettering explains whether or not PDL-1 is a sufficient biomarker in gastric disease. She…
Yelena Yuriy Janjigian, MD of Memorial Sloan-Kettering discusses her presentation, Is Surgery Required After Chemoradiotherapy for Squamous Cancer of the…
http://cancertherapeutics.alliedacademies.com/
Cathy Eng, MD, FACP of MD Anderson Cancer Center discusses her second presentation, which focused on management of anal carcinoma.…
Cathy Eng, MD, FACP of MD Anderson Cancer Center gives an overview of her first presentation, Is Circulating Tumor DNA…
Michael Choti, MD, MBA of UT Southwestern Medical Center gives an overview of his presentation, Is There a Role for…
Michael Choti, MD, MBA of UT Southwestern Medical Center discusses questions from the audience on how to manage early stage…
Zsofia K. Stadler, MD of Memorial Sloan-Kettering explains the role of aspirin therapy in patients with colon cancer and other…
Zsofia K. Stadler, MD of Memorial Sloan-Kettering gives an overview of her second presentation, which focused on the role of…
Tanios S. Bekaii-Saab, MD, FACP of Mayo Clinic gives an overview of his second presentation, which focused on optimal adjuvant…
Tanios S. Bekaii-Saab, MD, FACP of Mayo Clinic explains whether or not there is a standard second line treatment for…
Tanios S. Bekaii-Saab, MD, FACP of Mayo Clinic gives an overview of his first presentation, which focused on the availability…
Tanios S. Bekaii-Saab, MD, FACP of Mayo Clinic explains how to integrate HER2, BRAF, and immunotherapy into clinical practice. This…
Eric Van Cutsem, MD, PhD of University of Leuven gives an overview of his presentation which focused on how to…
Eric Van Cutsem, MD, PhD of University of Leuven gives an overview of his second presentation, which focused on the…
Eric Van Cutsem, MD, PhD of University of Leuven discusses the impact of left-sided tumors versus right-sided tumors on research…
Scott Kopetz, MD, PhD, FACP of MD Anderson Cancer Center discusses the use of technology and its potential breakthroughs for…
Scott Kopetz, MD, PhD, FACP of MD Anderson Cancer Center gives an overview of his presentation, which focused on treatment…
Scott Kopetz, MD, PhD, FACP of MD Anderson Cancer Center gives an overview of the novel therapies that are being…
Christopher Leigh Hallemeier, MD of Mayo Clinic gives an overview of Dr. Julio Garcia-Aguilar’s latest research trial, A Phase II…
Christopher Leigh Hallemeier, MD of Mayo Clinic gives an overview of his presentation, Is Observation Without Surgery Reasonable for Rectal…
Christopher Leigh Hallemeier, MD of Mayo Clinic explains whether or not clinicians can use non-operative management for patients with stage…
Julio Garcia-Aguilar, MD, PhD of Memorial Sloan-Kettering gives an overview of new data regarding watch-and-wait approaches in patients with rectal…
Julio Garcia-Aguilar, MD, PhD of Memorial Sloan-Kettering gives an overview of his presentation, Is Observation Without Surgery Reasonable for Rectal…
Julio Garcia-Aguilar, MD, PhD of Memorial Sloan-Kettering discusses patient concerns of risks with delaying surgery months or years after receiving…
http://cancertherapeutics.alliedacademies.com/ Cancer Therapeutics 2017 will be a great platform for research scientists and young researchers to share their current findings…
Crystal S. Denlinger, MD, FACP of Fox Chase Cancer Center gives an overview of her presentation, which discusses the survivorship…
Crystal S. Denlinger, MD, FACP of Fox Chase Cancer Center gives an overview of her poster presentation, which was a…
Crystal S. Denlinger, MD, FACP of Fox Chase Cancer Center explains the importance of clinicians speaking about diet, exercise, and…
Becky Lowry, MD of University of Kansas Medical Center gives an overview of her presentation, Survivorship Transitions to Adulthood and…
Becky Lowry, MD of University of Kansas Medical Center discusses the importance of communication between clinicians and survivors during survivorship…
Junne Kamihara, MD, PhD of Dana-Farber Cancer Institute gives an overview of her presentation, TP53 Mutation Carriers: Cancer Genetics in…
Junne Kamihara, MD, PhD of Dana-Farber Cancer Institute explains the significance of the shift from single gene testing to multiplex…
Angela R. Bradbury, MD of Perelman School of Medicine at the University of Pennsylvania discusses the integration of information on…
Angela R. Bradbury, MD of Perelman School of Medicine at the University of Pennsylvania discusses the challenges that came with…
Angela R. Bradbury, MD of Perelman School of Medicine at the University of Pennsylvania gives an overview of the key…
Grant Stewart, MBChB, FRCSEd (Urol), PhD, from the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK,…
Gerald Mickisch, MD, from the Bremen Center of Operative Urology, Bremen, Germany, discusses how sequential therapy can be used in…
Bertrand Tombal, MD, PhD, Catholic University of Leuven, Leuven, Belgium, discusses the ARASENS trial for prostate cancer at the European…
Anne Kiltie, MD, MRCP(UK), FRCR, from the University of Oxford, Oxford, UK, discusses bladder preservation in muscle invasive bladder cancer…
Morgan Roupret, MD, PhD, from the Pitié-Salpétrière Hospital, Paris, France, discusses what uro-oncologists should know about new drugs in 2017…
Morgan Roupret, MD, PhD, from the Pitié-Salpétrière Hospital, Paris, France, discusses optimization of contemporary bladder cancer care at the European…
Mark Emberton, MD, FRCS Urol, from University College London Hospitals NHS Foundation Trust, London, UK, discusses the potential of intraprostatic…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Philip D. Bonomi discusses new approaches to the…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Nurse Beth Eaby-Sandy discusses how to communicate with families…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Vera Hirsh discusses the role of zoledronic acid,…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Corey J. Langer discusses the targeting of angiogenesis…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Ranee Mehra discusses the management of T790-negative EGFR-mutated…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Tracey L. Evans discusses the management of T790-positive…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Vera Hirsh discusses how, when, and where to…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Barbara A. Burtness discusses current and future strategies…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Vassiliki Papadimitrakopoulou discusses the changing face of first-…
In this discussion, the co-chairs of the European Focus on Myeloproliferative Neoplasms & Myelodysplastic Syndromes 2017 highlight the key points…
Gokul Das, PhD of Roswell Park, Department of Pharmacology and Therapeutics describes the effect and consequences of when ER-p53 tumors…
Gokul Das, PhD of Roswell Park, Department of Pharmacology and Therapeutics describes his other study that focuses on the use…
Gokul Das, PhD of Roswell Park, Department of Pharmacology and Therapeutics discusses how to customize therapy based on the stratification…
Gokul Das, PhD of Roswell Park, Department of Pharmacology and Therapeutics gives an overview of his abstract, Novel effect of…
Valerie M. Weaver, PhD of UCSF Medical Center gives an overview of one of her presentations, The Effects of Tumor…
Valerie M. Weaver, PhD of UCSF Medical Center discusses the treatment trends for 2017 in oncology at the American Association…
Valerie M. Weaver, PhD of UCSF Medical Center gives an overview of one of her presentations, Taming the Tumor Microenvironment…
Valerie M. Weaver, PhD of UCSF Medical Center explains the importance in understanding the language of tumors for cancer research…
Valerie M. Weaver, PhD of UCSF Medical Center discusses the research on tumor microenvironment and its impact on cancer research…
Valerie M. Weaver, PhD of UCSF Medical Center explains how the genotype of a tumor affects overall tumor behavior and…
Solange Peters, MD, PhD of Lausanne University Hospital discusses the treatment trends for 2017 which include combination therapy and immunotherapy.…
Solange Peters, MD, PhD of Lausanne University Hospital discusses whether or not there is a correlation between biomarkers, specifically PD-L1…
Solange Peters, MD, PhD of Lausanne University Hospital discusses the impact of Checkmate-026 on current cancer research, stating the data…
Solange Peters, MD, PhD of Lausanne University Hospital gives an overview of her presentation, Impact of tumor mutation burden on…
Kishore Guda, DMV, PhD of Case Western Reserve University discusses the treatment trends for 2017 include immunotherapy and checkpoint inhibitors,…
Athena Matakidou of the Cambridge Cancer Centre discusses Preclinical models of renal cancer at the 12th European International Kidney Cancer…
Henry Withers of Roswell Park Cancer Institute, Department of Genetics gives an overview of his presentation, Characterization of an off-target…
Henry Withers of Roswell Park Cancer Institute, Department of Genetics discusses how the data can predict which patients are at…
Suzanne L. Topalian, MD of Johns Hopkins Kimmel Comprehensive Cancer Center explains where to place immunotherapy in overall treatment plans…
Suzanne L. Topalian, MD of Johns Hopkins Kimmel Comprehensive Cancer Center gives an overview of presentations that were discussed at…
Suzanne L. Topalian, MD of Johns Hopkins Kimmel Comprehensive Cancer Center explains the use of ipilimumab and nivolumab in advanced…
Suzanne L. Topalian, MD of Johns Hopkins Kimmel Comprehensive Cancer Center explains the importance of checkpoint inhibitors, specifically avelumab, in…
Suzanne L. Topalian, MD of Johns Hopkins Kimmel Comprehensive Cancer Center gives an overview of presentations at the AACR 2017…
Suzanne L. Topalian, MD of Johns Hopkins Kimmel Comprehensive Cancer Center gives an overview of the AACR presentations, which focused…
Kazuaki Takabe, MD, PhD of Roswell Park Cancer Institute discusses the use of liquid biopsies of microRNAs as a follow-up…
Kazuaki Takabe, MD, PhD of Roswell Park Cancer Institute describes the lack of immunotherapy in treatment for breast cancer, stating…
Kazuaki Takabe, MD, PhD of Roswell Park Cancer Institute gives an overview of his abstract, Novel microRNA signature score to…
Kazuaki Takabe, MD, PhD of Roswell Park Cancer Institute discusses whether or not early detection of metastasis can help overall…
Brian Rini, MD, Bernard Escudier, MD, James Larkin, MD and Cora N Sternberg, MD outline the challenges and Navigating the…
Jonathan D. Powell, MD, PhD of Johns Hopkins University, School of Medicine explains what types of tumors would the new…
Jonathan D. Powell, MD, PhD of Johns Hopkins University, School of Medicine discusses the treatment trends for 2017 which include…
Jonathan D. Powell, MD, PhD of Johns Hopkins University, School of Medicine explains the importance of targeting metabolism for cancer…
Jonathan D. Powell, MD, PhD of Johns Hopkins University, School of Medicine discusses his presentation topic, Immunometabolism in Immunotherapy, which…
Mateusz Opyrchal, MD, PhD of Roswell Park Cancer Institute discusses the treatment trends for 2017 in cancer, which includes immunotherapy.…
Mateusz Opyrchal, MD, PhD of Roswell Park Cancer Institute explains whether or not AURKA will play a role in melanoma…
Mateusz Opyrchal, MD, PhD of Roswell Park Cancer Institute discusses how the data from the AURKA study shows a possibility…
Mateusz Opyrchal, MD, PhD of Roswell Park Cancer Institute gives an overview of his abstract, Inhibition of AURKA induces Raf1-independent…
Richard Koya, MD, PhD of Roswell Park Cancer Institute explains the treatment trends for 2017, which include immunotherapy, t-cell therapy,…
Richard Koya, MD, PhD of Roswell Park Cancer Institute explains the significance of how tumors evolve from one type of…
Richard Koya, MD, PhD of Roswell Park Cancer Institute discusses the process of manufacturing products for research at Roswell Park.…
Richard Koya, MD, PhD of Roswell Park Cancer Institute discusses how the persistency of t-cell receptors against cancer can be…
Richard Koya, MD, PhD of Roswell Park Cancer Institute gives an overview of his presentation, Sustained efficacy of immunotherapy for…
Richard Koya, MD, PhD of Roswell Park Cancer Institute explains how the new data on T-Cell receptors impacts next generation…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Evan W. Alley discusses the role of angioinhibition…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Charles B. Simone, II elucidates use of IMRT,…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Charu Aggarwal discusses attempts to integrate novel targeted…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Tracey L. Evans discusses whether there are any…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Charles B. Simone, II argues in favor of…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Harvey I. Pass argues in favor of surgery…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Anil Vachani discusses when and how to intervene…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Anil Vachani discusses the impact of the National…
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Shakun M. Malik discusses novel protocol designs in…
Jürgen Gschwend, MD, PhD of the Technical University of Munich School of Medicine and Viktor Grünwald MD, PhD of the…
Howard L. Kaufman, MD, FACS of Rutgers Cancer Institute of New Jersey discusses the treatment trends for 2017. He explains…
Howard L. Kaufman, MD, FACS of Rutgers Cancer Institute of New Jersey gives an overview of presentations at AACR 2017…
Howard L. Kaufman, MD, FACS of Rutgers Cancer Institute of New Jersey gives an overview of his current research, a…
Howard L. Kaufman, MD, FACS of Rutgers Cancer Institute of New Jersey explains whether or not there is a biomarker…
Howard L. Kaufman, MD, FACS of Rutgers Cancer Institute of New Jersey explains the impact of data on future research,…
Howard L. Kaufman, MD, FACS of Rutgers Cancer Institute of New Jersey discusses the use of avelumab, a new agent…
Jean-Pierre J. Issa, MD of Fox Chase Cancer Center Fels Institute for Cancer Research & Molecular Biology at Temple University discusses…
Jean-Pierre J. Issa, MD of Fox Chase Cancer Center Fels Institute for Cancer Research & Molecular Biology at Temple University explains…
Jean-Pierre J. Issa, MD of Fox Chase Cancer Center Fels Institute for Cancer Research & Molecular Biology at Temple University gives…
Jean-Pierre J. Issa, MD of Fox Chase Cancer Center Fels Institute for Cancer Research & Molecular Biology at Temple University gives…
Jean-Pierre J. Issa, MD of Fox Chase Cancer Center Fels Institute for Cancer Research & Molecular Biology at Temple University discusses…
Jean-Pierre J. Issa, MD of Fox Chase Cancer Center Fels Institute for Cancer Research & Molecular Biology at Temple University discusses…
Kishore Guda, DMV, PhD of Case Western Reserve University gives an overview of his presentation, Mutational Landscapes of African American…
Kishore Guda, DMV, PhD of Case Western Reserve University explains how mutations in genes could potentially be used as biomarkers.…
Kishore Guda, DMV, PhD of Case Western Reserve University stresses the importance of finding data from diverse ethnic populations. He…
Kishore Guda, DMV, PhD of Case Western Reserve University discusses the existing social stigmas for ethnic populations in cancer research.…
David Goodrich, PhD of Roswell Park Cancer Institute, Department of Pharmacology and Therapeutics explains the use of combination therapy to…
David Goodrich, PhD of Roswell Park Cancer Institute, Department of Pharmacology and Therapeutics discusses his hopes for new clinical trials…
David Goodrich, PhD of Roswell Park Cancer Institute, Department of Pharmacology and Therapeutics discusses his hopes for new targets to…
David Goodrich, PhD of Roswell Park Cancer Institute, Department of Pharmacology and Therapeutics explains whether or not variant cells pre-exist…
David Goodrich, PhD of Roswell Park Cancer Institute, Department of Pharmacology and Therapeutics explains the transformation of cancers into stem-cell…
David Goodrich, PhD of Roswell Park Cancer Institute, Department of Pharmacology and Therapeutics gives an overview of his abstract, Rb1…
David Goodrich, PhD of Roswell Park Cancer Institute, Department of Pharmacology and Therapeutics discusses the treatment trends for prostate cancer…
Toni Choueiri, MD and David McDermott, MD discusses the Immuno-Oncology: Changing the Treatment Landscape in RCC at the 12th European…
Börje Ljungberg from UmeÃ¥ University Sweden discusses the Development of Guidelines in a Rapidly Changing Treatment Landscape for the John…
Bernard Escudier of the Gustave Roussy discusses Brain mets under I.O. at the 12th European International Kidney Cancer Symposium 2017
Guillermo de Velasco MD, PhD University Hospital 12 de Octubre discusses SBRT for lung metastases: Case report at the 12th…
Manuela Schmidinger of the Medical University of Vienna discusses the Solitary Bone Mets Spinal at the 12th European International Kidney…
Camillo Porta, MD of the I.R.C.C.S. San Matteo University Hospital Foundation answers the question How should the next generation of…
Gabriel Malouf, MD, PhD of Pitié-Salpêtrière Hospital Defines Optimal 2nd Line Treatment and Sequence: Biomarker at the 12th European International…
In this presentation from the 14th Annual Best of San Antonio – Breast Cancer: Bench to Bedside, Dr. Eric P.…
In this presentation from the 14th Annual Best of San Antonio – Breast Cancer: Bench to Bedside, Dr. Dawn L.…
In this presentation from the 14th Annual Best of San Antonio – Breast Cancer: Bench to Bedside, Dr. Constantine Godellas…
David McDermott, MD of the Dana-Farber/Harvard Cancer Center outlines and Defines Optimal 2nd Line Treatment and Sequence: Subgroup Analysis from…
John B.A.G. Haanen MD PhD of the The Netherlands Cancer Institute discusses Anti-PD1 PDL1 + anti-VEGFR in Kidney Cancer at…
Toni K. Choueiri, MD of the Dana-Farber Cancer Institute discusses the changes in first line kidney cancer treatment for 2018…
Thomas Powles MD of Barts Cancer Institute discusses the Phase II Study of Atezolizumab With or Without Bevacizumab vs Sunitinib…
Hans Hammers, MD, PhD, UT Southwestern discusses the Dual Immune Checkpoint Blockade at the  12th European International Kidney Cancer Symposium…
Alain Ravaud, MD.PhD takes the pro side of the debate entitled Adjuvant Therapy Ready For Prime Time In Kidney Cancer…
Tanja de Gruijl, VU University Medical Center discusses Harnessing the sentinel lymph node Translational perspective: LN as the first priming…
Prof. Dr. med. Viktor Grünwald of the Medical School Hannover outlines the Oncologists perspective LN as metastatic spread at the…
Jose A. Karam, MD, FACS, Associate Professor Department of Urology MD Anderson Cancer Center discusses Surgeons Perspective: LN as a…
Aung Naing of MD Anderson Cancer Center discusses PEGylated Human IL-10 AM0010 in Combination with Nivolumab in Renal Cell Cancer…
Cynthia Macahilig of the University of Manchester discusses Health-Related Quality of Life, Treatment Satisfaction, and Work Productivity for Patients With…